drugset / Trial / NCT01616654
Dose Range Study of CD5789 in Acne Vulgaris
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To assess the efficacy and safety of different concentrations of CD5789 cream in participants with acne vulgaris for the purpose of dose identification.
Timeline
- Start
- 2012-06-20
- Primary completion
- 2013-07-24
- Completion
- 2014-06-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tazarotene | Small molecule | 0.1 % | Topical |
| Subject | Trifarotene | Small molecule | 25 unknown | Topical |
| Subject | Trifarotene | Small molecule | 50 unknown | Topical |
| Subject | Trifarotene | Small molecule | 100 unknown | Topical |